Treatment of Clonidine Overdose
Clonidine overdose should be managed primarily with supportive care, including close monitoring of vital signs, atropine for symptomatic bradycardia, and high-dose naloxone (up to 10 mg IV) for sedation and respiratory depression, particularly in pediatric patients. 1, 2
Initial Assessment and Monitoring
- Symptoms typically develop within 30 minutes to 2 hours after ingestion and include sedation, bradycardia, hypotension, respiratory depression, hypothermia, miosis, and decreased reflexes 1
- CNS depression occurs more frequently in children than adults, and as little as 0.1 mg can produce toxicity in pediatric patients 1
- Large overdoses may cause reversible cardiac conduction defects, dysrhythmias, apnea, coma, and seizures 1
- Early hypertension may occur initially, followed by hypotension due to peripheral alpha-1 receptor stimulation at high doses, then central alpha-2 agonist effects 1, 3
Gastrointestinal Decontamination
- Do NOT induce vomiting with ipecac syrup due to rapid onset of CNS depression 1
- Gastric lavage may be indicated for recent and/or large ingestions 1
- Activated charcoal and/or cathartic administration may be beneficial 1
- Dialysis is not effective for enhancing clonidine elimination 1
Specific Pharmacologic Management
Bradycardia
- Atropine sulfate is the first-line treatment for symptomatic bradycardia and has been shown to effectively correct heart rate 1, 4, 5
Hypotension
- IV crystalloid volume expansion is the initial approach 1, 4
- Dopamine infusion should be used if hypotension persists despite fluid resuscitation 1, 4
- Vasopressor agents may be necessary in refractory cases 1
- Note that hypotension is relatively rare and often clinically insignificant, particularly in pediatric patients 2
Hypertension (Early Phase)
- Vasodilators should be used if significant hypertension develops, particularly in massive overdoses where peripheral alpha-1 stimulation predominates 1
Sedation and Respiratory Depression
- Naloxone is highly effective and should be considered first-line therapy for clonidine-induced sedation, respiratory depression, and coma 1, 2
- High-dose naloxone (up to 10 mg IV) is safe and more effective than traditional low doses (≤2 mg), particularly in pediatric patients 2
- In a pediatric cohort, naloxone awakened 40 of 51 somnolent patients, with 20 patients receiving 10 mg doses without any adverse effects 2
- Recurrent sedation may occur and responds to repeat naloxone boluses 2
- Monitor blood pressure during naloxone administration, as paradoxical hypertension has occasionally been reported 1
- High-dose naloxone may prevent the need for endotracheal intubation, which carries significant morbidity 2
Ineffective Therapies
- Tolazoline is NOT recommended as it has yielded inconsistent results and was found ineffective in reversing clonidine toxicity 1, 4
Critical Pitfalls to Avoid
- Do not assume naloxone is ineffective based on older literature that used inadequate doses (≤2 mg); current evidence supports high-dose naloxone (10 mg) as safe and effective 2
- Do not rush to intubate somnolent patients without first attempting high-dose naloxone, as this may prevent unnecessary procedural morbidity 2
- Persistent bradycardia after naloxone reversal of sedation is generally benign and does not require aggressive intervention unless hemodynamically significant 2
- Be aware that naloxone can potentiate hypertensive effects in massive overdoses, particularly when peripheral alpha-1 stimulation is prominent 3
- Recognize that compounding pharmacy errors can result in concentrations up to 8 times higher than labeled, causing unexpected toxicity 6
Disposition
- All patients require close monitoring of vital signs with supportive care tailored to specific physiologic abnormalities 4, 5
- Most patients recover fully with appropriate supportive management 1, 4, 5
- The largest reported overdose (100 mg in an adult) resulted in full recovery after intensive treatment 1